comparemela.com

Meningococcal Infection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novel Myasthenia Gravis Therapies Bring Opportunities

New treatments for myasthenia gravis are bringing new promise to patients, but their use must be balanced against short-term and long-term risks.

United statesJames howardPushpa narayanaswamiDrug administrationAmerican association for neuromuscular electrodiagnostic medicineAmerican associationElectrodiagnostic medicineMyasthenia gravisMuscular atrophyUscular atrophiesAdverse effectsSide effectsPatient safetyAbdominal painPain managementPain management

Peds Immunization Schedule Includes New RSV, Mpox Vaccines

Updated CDC guidance includes several new vaccines for children.

United statesMichael pichicheroCenters for diseaseAmerican academy of physician associatesHospital research instituteAdvisory committee on immunization practicesNational association of pediatric nurse practitionersAmerican academy of family physiciansAmerican academy of pediatricsAmerican college of obstetriciansDrug administrationAmerican college of nurseAmerican academyDisease controlFamily physiciansAmerican college

Sustained Benefit for Newly Approved Myasthenia Gravis Drug

Early responders to zilucoplan, the newly approved medication for myasthenia gravis have sustained benefit for up to 60 weeks, new analyses show.

United statesMiriam freimerDepartment of neurologyDrug administrationOhio state universityAmerican association of neuromuscular electrodiagnostic medicineDivision of neuromuscular disordersMg foundation of americaMedscape medicalNeuromuscular electrodiagnostic medicineMedscape medical newsDaily livingNeuromuscular disordersMyasthenia gravis clinicMyasthenia gravisMuscular atrophy

Tripledemic : Your Questions Answered

A second flu vaccine? Immunization and the immunocompromised? The CDC s Dr Manisha Patel answers questions from the recent Medscape Masters panel on this year s respiratory virus season.

United statesEric topolManisha patelPneumorecs vaxadvisorAdvisory committee on immunization practicesInfectious diseases society of americaAdvisory committeeImmunization practicesInfectious diseases society019 novel coronavirus019 ncovUhan coronavirusUman coronavirus hku1Uman coronavirus oc43Cov oc43Uman coronavirus 229e

New Meningococcal Vaccine Wins FDA Approval

The single shot will cover the five most common serogroups that cause meningococcal disease in children and young adults.

United statesNew yorkAnnaliesa andersonJana shawAdvisory committee on immunization practicesUs centers for diseaseDrug administrationFive commonUpstate golisano childrenDisease controlImmunization practicesMeningococcal infectionMeningococcal diseaseMeningococcal vaccineMeningitis vaccineYoung adult

vimarsana © 2020. All Rights Reserved.